The US Alcohol and Tobacco Tax and Trade Bureau (TTB) warned alcoholic drinks manufacturers to limit the use of the word "clean" to describe a flavor, not to imply health claims.
All alcoholic beverages must also bear a health risk warning, according to the TTB's existing labeling requirements, and the word "clean" isn't a method to soften that message.
The TTB admitted that its regulations do not define the word 'clean,' and that they do not have standards for the use of the term on labels or in advertisements.
It warned that consumers should not interpret the term as meaning that the beverage is organic or has met other production standards set by TTB.
The TTB noted that the word clean is being used along with other teams to create the misleading impression that consuming the alcoholic beverage will have health benefits, or that the health risks of alcohol consumption will be mitigated.


California Sues Trump Administration Over Federal Authority on Sable Offshore Pipelines
Federal Judge Restores Funding for Gateway Rail Tunnel Project
Instagram Outage Disrupts Thousands of U.S. Users
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Newly Released DOJ Epstein Files Expose High-Profile Connections Across Politics and Business
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Trump Family Files $10 Billion Lawsuit Over IRS Tax Disclosure
Jerome Powell Attends Supreme Court Hearing on Trump Effort to Fire Fed Governor, Calling It Historic
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 



